CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 121 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $162,000 | +38.5% | 20,978 | +18.8% | 0.02% | -5.3% |
| Q3 2020 | $117,000 | +25.8% | 17,660 | +57.6% | 0.02% | +35.7% |
| Q2 2020 | $93,000 | -47.5% | 11,208 | -53.3% | 0.01% | -54.8% |
| Q3 2019 | $177,000 | -63.7% | 23,998 | +39.7% | 0.03% | -57.5% |
| Q1 2018 | $488,000 | -30.2% | 17,178 | -55.4% | 0.07% | -35.4% |
| Q3 2017 | $699,000 | +239.3% | 38,485 | +221.9% | 0.11% | +135.4% |
| Q1 2017 | $206,000 | – | 11,956 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
| Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
| Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
| HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
| XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
| Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
| RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
| Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
| Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
| Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |